EnteroMedics
EnteroMedics® Inc. (NASDAQ: ETRM) is the developer of in-class weight loss treatments for obesity and obesity related risk factors.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed EnteroMedics Information
Geographic Data
Address:
City: Saint Paul
State: Minnesota
Zip:
Country: United States
Financial Info
Stage:
post ipo equity
Raised Last:
$61M
Raised Total:$161M
Social
Metrics
924,573Website Global Rank
44,893Website Monthly Traffic
Twitter Followers
Description
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.
Contact Phone:
Contact Email:
EnteroMedics went public on 11/15/2007 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/15/2007
IPO Valuation:
$128M
Ticker Symbol:
ETRM
IPO Price:
$8/share
Amount Raised:
$40M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2017 | Post-IPO Equity | $2M | 10/2017 | Post-IPO Equity | $61M | 9/2010 | Post-IPO Equity | 3 | $6.3M |
Aberdare Ventures MPM Capital Bay City Capital Aberdare Ventures MPM Capital Bay City Capital |
5/2016 | Post-IPO Debt | $6M | 8/2017 | Post-IPO Equity | $18.1M | 11/2004 | Series B | $16.9M | 2/2009 | Post-IPO Equity | $15.9M | 1/2017 | Post-IPO Equity | $19M | 7/2015 | Post-IPO Equity | $16M | 7/2004 | Series A | 1 | - |
Bay City Capital Bay City Capital |
7/2004 | Series A | 1 | - |
Bay City Capital Bay City Capital |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 10/2017 | ReShape Lifesciences | |
| 5/2017 | BarioSurg |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
